Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): A randomised controlled trial

Roy S. Herbst, Paul Baas, Dong Wan Kim, Enriqueta Felip, José L. Pérez-Gracia, Ji Youn Han, Julian Molina, Joo Hang Kim, Catherine Dubos Arvis, Myung Ju Ahn, Margarita Majem, Mary J. Fidler, Gilberto De Castro, Marcelo Garrido, Gregory M. Lubiniecki, Yue Shentu, Ellie Im, Marisa Dolled-Filhart, Edward B. Garon

Research output: Contribution to journal › Article › peer-review

3430 Scopus citations

Fingerprint

Dive into the research topics of 'Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): A randomised controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences